On this page ▾
The market expects much less from UPL than it has delivered before.
At today’s share price, buyers are assuming UPL grows about 0% a year, forever. Over the last ten years it actually grew about 6% a year. That is a big step down from its own record — in other words, that it stops growing altogether. Either the market can see a problem that the published accounts do not show yet, or it is expecting a slowdown that has not happened.
- How it is valued: Discounted cash flow.
- What the price assumes: 0% growth, against 6% the model takes from its own record.
- Ten-year record: Between FY2019 and FY2026, UPL's revenue went from ₹21,837 crore to ₹51,839 crore — it compounded at about 13% a year over 7 years.
- Biggest swing factor: Global farm demand. Main risk: Chinese generics.
01From Mumbai to the world's farms
UPL, controlled by the Shroff family, is one of the world's largest makers of generic crop-protection products — herbicides, insecticides and fungicides — with a large presence in Latin America, North America, Europe and India.
It bought Arysta LifeScience in 2019, which roughly doubled its size, and owns seeds business Advanta. The acquisition added significant debt.
02What the market is assuming
Work backwards from today's share price and you can see what buyers are quietly taking for granted. Here is the growth that price implies for UPL, next to what the model assumes from the company's own record.
The further apart these two numbers are, the bigger the bet a buyer at today's price is making.
03UPL's record, in plain numbers
Between FY2019 and FY2026, UPL's revenue went from ₹21,837 crore to ₹51,839 crore — it compounded at about 13% a year over 7 years. It reported a net loss in FY2024, and closed the period with net profit of ₹2,220 crore. In FY2026 it kept 4.3% of revenue as net profit — against a low of -4.4% in FY2024 and a high of 9.6% in FY2022. The latest year added 11.2% to revenue, close to its own long-run pace.
Revenue and earnings per share in ₹, return on equity and leverage as ratios — all from the filed statements.
Revenue and net profit by year (₹ crore)
| Year | Revenue | Net profit | Margin |
|---|---|---|---|
| FY2019 | 21,837 | 1,519 | 7.0% |
| FY2020 | 35,756 | 2,178 | 6.1% |
| FY2021 | 38,694 | 3,495 | 9.0% |
| FY2022 | 46,240 | 4,437 | 9.6% |
| FY2023 | 53,576 | 4,414 | 8.2% |
| FY2024 | 43,098 | -1,878 | -4.4% |
| FY2025 | 46,637 | 820 | 1.8% |
| FY2026 | 51,839 | 2,220 | 4.3% |
04How UPL gets valued — and why
Discounted cash flowThis business is valued on the cash it is expected to generate, discounted back at its cost of capital — with growth taken from its own ten-year record rather than from guidance.
05What decides UPL's value
Global farm demand
Crop prices and planting drive sales.
Channel inventory
Distributor stock levels swing volumes.
Debt reduction
Lower debt cuts interest costs.
Advanta seeds
A faster-growing, higher-margin business.
06What could go wrong
- Chinese generics. Low-priced Chinese products pressure prices.
- Leverage. High debt magnifies downturns.
- Weather and currencies. Brazil and Argentina conditions matter a lot.
07What the full UPL valuation shows
Sign in free to see the complete UPL valuation
- ✓Fair value per share — from a ten-year discounted cash flow, every step shown
- ✓The Workbench — change revenue growth, the discount rate or terminal growth and watch UPL's value move
- ✓Bull, base and bear cases — and exactly which assumptions move between them
- ✓Peer comparison — against Coromandel, PI Industries and other agri-input companies
- ✓Downloadable report — the full write-up, yours to keep
08Questions people ask about UPL
What does UPL make?
Herbicides, insecticides, fungicides and seeds.
Why did UPL report a loss in FY2024?
Distributors cut inventories worldwide and prices fell.
What was the Arysta deal?
UPL's 2019 acquisition of Arysta LifeScience, which roughly doubled its size.
Is UPL overvalued?
At ₹559 the market is pricing in roughly 0% sustained growth, against the ~6% its own record supports. That is less than it has delivered — on these numbers the market is asking the business for less than its own record, which usually means it doubts the record repeats.
What is the intrinsic value of UPL?
It is computed from the filed financial statements using the method that fits this business (discounted cash flow), with every assumption shown alongside the result. The per-share figure and the full working are in the report.
How much debt does UPL carry?
Debt to equity stands at 0.63, down from 0.97 at the start of the period — the balance sheet is a core input to the cost of capital used here.